Home
About us
Products
Research
Operations
Finance
Marketing
NATCO Trust
Sitemap
Contact Us
Download Adobe Reader Here..
Audited Financial Results
2009 - 2010
Natco Pharma Limited
Natco Pharma, INC, T/A Savemart
2008 - 2009
Natco Pharma, INC. T/A Savemart
Natco Pharma Limited
2007 - 2008
Natco Pharma, INC. T/A Savemart
Natco Pharma Limited
2006 - 2007
Un-audited Financial Results
2010 - 2011
2009 - 2010
Quarter-III
Quarter-II
Quarter-I
2008 - 2009
Quarter-III
Quarter-II
Quarter-I
2007 - 2008
2006 - 2007
Annual Report
2009 - 2010
2008 - 2009
2007 - 2008
2006 - 2007
Shareholding Pattern
Board of Directors
NATCO confirms filing of ANDA for Generic Revlimid 31/08/2010
NATCO denies speculative news 23/08/2010
NATCO reports increased earnings and profits 31/07/2010
NATCO launches Anastrazole in the USA 29/06/2010
NATCO records higher sales, profits 25/06/2010
NATCO launches BENDIT 07/04/2010
NATCO declares an interim dividend of Rs. 2 per share 27/01/2010
Press Release 09/01/2010
NATCO records increase in revenues, profits 29/10/2009
Natco’s note on anti-cancer drug Albupax 19/10/2009
NATCO Pharma launches Swine Flu medicine 18/09/2009
NATCO’s partner – Mylan’s – ANDA accepted for review of Glatiramer Acetate 14/09/2009
News
|
Careers
|
Privacy Policy
NATCO House, Road No: 2, Banjara Hills, Hyderabad - 500 033
Powered by
www.sholay.in